receptor, tyrosyl-prolyl-leucyl-glycinamide

Known as: tyrosyl-prolyl-leucyl-glycinamide receptor, tyrosyl-prolyl-leucyl-glycinamide receptors, Tyr-Pro-Leu-Gly-NH2 receptor 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2011
0119992011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
A novel series of indolyl and dihydroindolyl glycinamides were identified as potent NPY5 antagonists with in vivo activity from… (More)
Is this relevant?
2011
2011
Subtype specific ligands are needed to evaluate the therapeutic potential of modulating the brain's neuropeptide Y system. The… (More)
  • table 1
  • table 4
  • table 2
  • table 3
Is this relevant?
2004
2004
A novel series of dihydro- and tetrahydrotriazolopyridazine-1,3-dione-based amino acid derivatives were identified as very potent… (More)
Is this relevant?
2002
2002
Excitotoxicity has been implicated in the etiology of ischemic stroke, chronic neurodegenerative disorders, and very recently, in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2001
2001
This thesis describes the incorporation of heterocycles as part of an a-amino acid side-chain. Two methods were adopted. The… (More)
  • figure 1.2
  • figure 1.2
  • figure 2.1
  • figure 2.3
  • figure 2.4
Is this relevant?
1999
1999
Glycine is a major inhibitory neurotransmitter and recent reports have shown that certain lipophilic derivatives of glycine… (More)
Is this relevant?